본문 바로가기
KERD
논문KCI 등재

Anti-Müllerian Hormone Negatively Regulates Osteoclast Differentiation by Suppressing the Receptor Activator of Nuclear Factor-κB Ligand Pathway

김낙성|김정하|양용열|권기선
대한골대사학회 (The Korean Society of Bone Metabolism)|2021.08|대한골대사학회지 (Journal of Bone Metabolism)|제28권 제3호|pp. 223-230

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

OsteoclastsOsteoblastsAnti-müllerian hormoneTGF-beta superfamily proteins
주제분류정형외과학

초록

Background: Multiple members of the transforming growth factor-β (TGF-β) superfamily have well-established roles in bone homeostasis. Anti-Müllerian hormone (AMH) is a member of TGF-β superfamily of glycoproteins that is responsible for the regression of fetal Müllerian ducts and the transcription inhibition of gonadal steroidogenic enzymes. However, the involvement of AMH in bone remodeling is unknown. Therefore, we investigated whether AMH has an effect on bone cells as other TGF-β superfamily members do. Methods: To identify the roles of AMH in bone cells, we administered AMH during osteoblast and osteoclast differentiation, cultured the cells, and then stained the cultured cells with Alizarin red and tartrate-resistant acid phosphatase, respectively. We analyzed the expression of osteoblast- or osteoclast-related genes using real-time polymerase chain reaction and western blot. Results: AMH does not affect bone morphogenetic protein 2-mediated osteoblast differentiation but inhibits receptor activator of nuclear factor-κB (NF-κB) ligand-induced osteoclast differentiation. The inhibitory effect of AMH on osteoclast differentiation is mediated by IκB-NF-κB signaling. Conclusions: AMH negatively regulates osteoclast differentiation without affecting osteoblast differentiation.

Abstract

Background: Multiple members of the transforming growth factor-β (TGF-β) superfamily have well-established roles in bone homeostasis. Anti-Müllerian hormone (AMH) is a member of TGF-β superfamily of glycoproteins that is responsible for the regression of fetal Müllerian ducts and the transcription inhibition of gonadal steroidogenic enzymes. However, the involvement of AMH in bone remodeling is unknown. Therefore, we investigated whether AMH has an effect on bone cells as other TGF-β superfamily members do. Methods: To identify the roles of AMH in bone cells, we administered AMH during osteoblast and osteoclast differentiation, cultured the cells, and then stained the cultured cells with Alizarin red and tartrate-resistant acid phosphatase, respectively. We analyzed the expression of osteoblast- or osteoclast-related genes using real-time polymerase chain reaction and western blot. Results: AMH does not affect bone morphogenetic protein 2-mediated osteoblast differentiation but inhibits receptor activator of nuclear factor-κB (NF-κB) ligand-induced osteoclast differentiation. The inhibitory effect of AMH on osteoclast differentiation is mediated by IκB-NF-κB signaling. Conclusions: AMH negatively regulates osteoclast differentiation without affecting osteoblast differentiation.

참고문헌 (33)

  1. Natalie A Sims, "Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit", BoneKEy Reports, 3, pp.481~ (2014), Portico[DOI]
  2. Siddhartha Sharma, "Epigenetic and transcriptional regulation of osteoclastogenesis in the pathogenesis of skeletal diseases: A systematic review", Bone, 138, pp.115507~ (2020), Elsevier BV[DOI]
  3. Tilman D Rachner, "Osteoporosis: now and the future", The Lancet, 377(9773), pp.1276~1287 (2011), Elsevier BV[DOI]
  4. Kamala Gullapalli Cotts, "Treatment of Osteoporosis", JAMA, 319(10), pp.1040~1041 (2018), American Medical Association (AMA)[DOI]
  5. Zornitza Stark, "Osteopetrosis", Orphanet Journal of Rare Diseases, 4(1), pp.5~ (2009), Springer Science and Business Media LLC[DOI]
  6. Jessica Jann, "Influence of the TGF-β Superfamily on Osteoclasts", Osteoblasts Balance in Physiological and Pathological Bone Conditions, 2020, pp.21(20), 7597~[DOI]
  7. Gavin Walters, "The cytokines and micro‐environment of fracture haematoma: Current evidence", Journal of Tissue Engineering and Regenerative Medicine, 12(3), pp.e1662~e1677 (2018), Wiley[DOI]
  8. Guiqian Chen, "TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation", International Journal of Biological Sciences, 8(2), pp.272~288 (2012), Ivyspring International Publisher[DOI]
  9. Thomas A. Linkhart, "Growth factors for bone growth and repair: IGF, TGFβ and BMP", Bone, 19(1), pp.S1~S12 (1996), Elsevier BV[DOI]
  10. HONGWEI CHENG, "OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)", The Journal of Bone and Joint Surgery-American Volume, 85(8), pp.1544~1552 (2003), Ovid Technologies (Wolters Kluwer Health)[DOI]
  11. Q Kang, "Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery", Gene Therapy, 11(17), pp.1312~1320 (2004), Springer Science and Business Media LLC[DOI]
  12. Jing Cui, "BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells", Laboratory Investigation, 99(1), pp.58~71 (2019), Springer Science and Business Media LLC[DOI]
  13. Yang Zhang, "Efficiency of coculture with angiogenic cells or physiological BMP-2 administration on improving osteogenic differentiation and bone formation of MSCs", Journal of Biomedical Materials Research Part A, 107(3), pp.643~653 (2019), Wiley[DOI]
  14. Ping SUN, "BMP2", 7 heterodimer is a stronger inducer of bone regeneration in peri-implant bone defects model than BMP2 or BMP7 homodimer, 2012, pp.31(2), 239~248[DOI]
  15. Keita Tachi, "Enhancement of Bone Morphogenetic Protein-2-Induced Ectopic Bone Formation by Transforming Growth Factor-β1", Tissue Engineering Part A, 17(5-6), pp.597~606 (2011), Mary Ann Liebert Inc[DOI]
  16. Hai Li, "Bone morphogenetic protein-9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1", 2 pathways in vitro, 2016, pp.14(5), 4545~4550[DOI]
  17. Yuanna Zheng, "BMP2", 7 Heterodimer Can Modulate All Cellular Events of theIn VitroRANKL-Mediated Osteoclastogenesis, Respectively, in Different Dose Patterns, 2012, pp.18(5-6), 621~630[DOI]
  18. Mary Karst, "Roles of stromal cell RANKL, OPG, and M‐CSF expression in biphasic TGF‐β regulation of osteoclast differentiation", Journal of Cellular Physiology, 200(1), pp.99~106 (2004), Wiley[DOI]
  19. Bitnara Lee, "A dual role of TGF-β in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling", Immunology Letters, 206, pp.33~40 (2019), Elsevier BV[DOI]
  20. Anna Li, "Pharmacologic Calcitriol Inhibits Osteoclast Lineage Commitment via the BMP-Smad1 and IκB-NF-κB Pathways", Journal of Bone and Mineral Research, 32(7), pp.1406~1420 (2017), Wiley[DOI]
  21. Jenny A. Visser, "AMH signaling: from receptor to target gene", Molecular and Cellular Endocrinology, 211(1-2), pp.65~73 (2003), Elsevier BV[DOI]
  22. AL Durlinger, "Regulation of ovarian function: the role of anti-Mullerian hormone", Reproduction, 124, pp.601~609 (2002), Bioscientifica[DOI]
  23. Jose Teixeira, "Müllerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications", Endocrine Reviews, 22(5), pp.657~674 (2001), The Endocrine Society[DOI]
  24. MARY M. LEE, "Mullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions", Endocrine Reviews, 14(2), pp.152~164 (1993), The Endocrine Society[DOI]
  25. Sayaka Ogura-Nose, "Anti-Mullerian hormone (AMH) is induced by bone morphogenetic protein (BMP) cytokines in human granulosa cells", European Journal of Obstetrics & Gynecology and Reproductive Biology, 164(1), pp.44~47 (2012), Elsevier BV[DOI]
  26. Jia Shi, "Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin", activin β subunits, and anti-Müllerian hormone in human granulosa cells, 2009, pp.92(5), 1794~1798[DOI]
  27. A. Ross, "<i>Bmp7<", i> Regulates Germ Cell Proliferation in Mouse Fetal Gonads, 2007, pp.1(2), 127~137[DOI]
  28. K. A. Lawson, "Bmp4 is required for the generation of primordial germ cells in the mouse embryo", Genes & Development, 13(4), pp.424~436 (1999), Cold Spring Harbor Laboratory[DOI]
  29. Shunichi Shimasaki, "The Bone Morphogenetic Protein System In Mammalian Reproduction", Endocrine Reviews, 25(1), pp.72~101 (2004), The Endocrine Society[DOI]
  30. Ermioni Prapa, "Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling", Journal of Assisted Reproduction and Genetics, 32(7), pp.1079~1088 (2015), Springer Science and Business Media LLC[DOI]
  31. Jenny A. Visser, "The Serine", Threonine Transmembrane Receptor ALK2 Mediates Müllerian Inhibiting Substance Signaling, 2001, pp.15(6), 936~945[DOI]
  32. Lucile Gouédard, "Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Müllerian Hormone and Its Type II Receptor", Journal of Biological Chemistry, 275(36), pp.27973~27978 (2000), Elsevier BV[DOI]
  33. Nathalie Josso, "Anti-Müllerian hormone and its receptors", Molecular and Cellular Endocrinology, 179(1-2), pp.25~32 (2001), Elsevier BV[DOI]

관련 논문AI추천

Lefty2 prevents RANKL-induced bone loss by inhibiting osteoclast differentiationInyoung Kim, Jung Ha Kim, Kabsun Kim, Nacksung Kim, Semun Seong생화학분자생물학회 · BMB Reports2026 · 제59권 제1호RIP function on osteoclastogenesis이준원한국지식정보기술학회 · 한국지식정보기술학회 논문지2015 · 제10권 제5호Negative regulators in RANKL-induced osteoclastogenesis김갑순, 김낙성, 이준원대한구강생물학회 · International Journal of Oral Biology2007 · 제32권 제1호Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways김나영, 임미정, Ting Zheng대한골대사학회 · 대한골대사학회지2017 · 제24권 제4호Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesisEun-Gyeong Lee, Myung-Soon Sung, Wan-Hee Yoo, Won-Seok Lee, Yun-Jung Choi대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제2호Deficiency of Lipocalin-2 Promotes Proliferation and Differentiation of Osteoclast Precursors via Regulation of c-Fms Expression and Nuclear Factorkappa B Activation강우열, 김신윤, 김현주, 석경호, 성숙진, 옥보람, 윤영란, 임미선대한골대사학회 · 대한골대사학회지2016 · 제23권 제1호

이 간행물의 다른 논문 (7건)

Two Types of Mouse Models for Sarcopenia Research: Senescence Acceleration and Genetic Modification Models김소정, 박진성, 김지석, 유준일, 백경완, 정연관, 하영술pp. 179-191Citation Analysis of the Journal of Bone Metabolism from Korean Citation Index, Web of Science, and Scopus김덕윤, 정은애, 윤병호, 황보권pp. 193-199The Trend in the Sales of Menopausal Hormone and Other Osteoporosis Medications in South Korea from 2016 to 2019이은실, 권소진, 박형무pp. 201-206Specific Bioactive Collagen Peptides in Osteopenia and Osteoporosis: Long-Term Observation in Postmenopausal WomenDenise Zdzieblik, Steffen Oesser, Daniel Königpp. 207-213Cross-Calibration of Bone Mineral Densities and Body Composition between GE Lunar Prodigy and Osteosys Primus하용찬, 유준일pp. 215-221
원문 보기